- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00657722
Identification of Criteria of the Success of the Endarterectomy in Chronic Pulmonary Post Embolic Hypertension (ETHAPE)
Identification Of The Predictive Angiographic And Computed Tomographic (CT) Criteria Of The Success Of The Thromboendarterectomy In Chronic Pulmonary Hypertension
Study Overview
Status
Intervention / Treatment
Detailed Description
Chronic thromboembolic pulmonary hypertension(CTEPH) is caused by obstruction of the large pulmonary arteries by acute and recurrent pulmonary emboli, and organization of these blood clots. ANTOINE BECLERE respiratory unit, in partnership with the MARIE LANNELONGUE hospital thoracic and vascular surgery departments was designated recently as reference national centre for pulmonary hypertension and represents the only French structure for evaluation of CTEPH with 150 patients addressed each year.If the disease is proximately located, CTEPH can be cured surgically through a complex surgical procedure performed under Hypothermia and total circulatory arrest. In spite of multidisciplinary meeting deciding the operability of each case the rate of failure is approximately of 15% (9% of operative mortality rate and 6% of technical failure).
The aim of this study is to identify predictive angiographic and CT findings of success, by allowing a better selection of operable patients.
It would be possible to improve the effectiveness of the surgical treatment and reduce the rate failure from 15% to 7 % or even 5 %.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Clamart, France, 92141
- Hôpital Antoine Béclère
-
Le Plessis Robinson, France, 92350
- Hospital Marie Lannelongue
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients addressed to the reference centre of pulmonary hypertension for a suspected CPC-PE
- Achieving an assessment prior to the operation, including:1) Right cardiac catheterization confirming HTP with a mean pulmonary arterial pressure> 25 mm Hg at rest; 2) Echography and Doppler of the lower limbs in search of phlebitis sequela; 3) Pulmonary scintigraphy with 6 views in ventilation and perfusion; 4) Digital pulmonary angiography; 5) A 64 detector pulmonary computed tomography; 6) Having read the briefing note and given their agreement.
Exclusion criteria:
- Refusal examinations .
- Patient for which one method is contraindicated
- Patient considered not operable by the staff
- Life expectancy of less than 3 months
- Geographical distance for the clinical follow-up at 3 months
- Renal insufficiency (creatinine clearance <30 mL / min)
- Proven allergy to iodinated contrast agents
- Pregnant woman.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
Angiography and Computed Tomography
|
Preoperative angiography and Computed Tomography
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
surgical effectiveness evaluated by the death or failure rate.
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
surgical effectiveness evaluated by the death or failure rate.
Time Frame: 3 months
|
3 months
|
Check that none of the patients considered unresectable on data from staff was declared operable with the criteria predictive success of imaging examinations.
Time Frame: before surgery
|
before surgery
|
Determine the interest of pulmonary angiography in the operability decision compared first to Multi detector AngioCT alone with standardized analyze and then with the both exams.
Time Frame: before surgery
|
before surgery
|
Determine the incidence of adverse events associated with each of these two exams or their combination.
Time Frame: 3 and 6 months after surgery
|
3 and 6 months after surgery
|
Check-inter-observer reproducibility of standardized reading grids of pulmonary angiography and MD-AngioCT
Time Frame: Before surgery
|
Before surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Mathieu LIBERATORE, MD, Assistance Publique - Hôpitaux de Paris Hôpital Antoine Béclère
- Study Director: Dominique MUSSET, MD, PhD, Assistance Publique - Hopitaux de Paris, Hôpital Antoine Beclere
- Study Director: Gerald SIMONNEAU, MD, PhD, Assistance Publique - Hopitaux de Paris, Hôpital Antoine Beclere
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- K060205
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Thromboembolic Pulmonary Hypertension
-
University of California, San FranciscoRecruitingChronic Thromboembolic Pulmonary Hypertension | Chronic Thromboembolic DiseaseUnited States
-
SciPharm SàRLCompletedNon-operable Chronic Thromboembolic Pulmonary HypertensionAustria, Poland, Czechia, Germany
-
University of ZurichCompletedPulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension | Chronic Cardiorespiratory DiseaseSwitzerland
-
ActelionEPS Corporation; Imepro Inc.; General Laboratory, BML, Inc.; Mitsubishi Logistics...TerminatedChronic Thromboembolic Pulmonary Hypertension (CTEPH)Japan
-
University of California, San DiegoE Squared Trials and Registries, Inc.CompletedPulmonary Hypertension | Chronic Thromboembolic Pulmonary Hypertension (CTEPH)United States
-
Assistance Publique - Hôpitaux de ParisMerck Sharp & Dohme LLCRecruitingPulmonary Embolism | Chronic Thromboembolic Pulmonary Hypertension (CTEPH)France
-
University of ZurichCompletedPulmonary Arterial and Chronic Thromboembolic Pulmonary HypertensionSwitzerland
-
University of SheffieldSheffield Teaching Hospitals NHS Foundation TrustUnknownChronic Thromboembolic Pulmonary Hypertension
-
University of AarhusHospitalsenheden VestUnknownChronic Thromboembolic Pulmonary Disease
-
China-Japan Friendship HospitalRecruitingChronic Thromboembolic Pulmonary HypertensionChina
Clinical Trials on Angiography and Computed Tomography
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedCoronary Artery Disease | Aortic Valve Disease | Computed Tomography Angiography | Coronary AngriographyNetherlands
-
Clinical Research Office Imaging DivisionCompletedAortic Aneurysm, AbdominalNetherlands
-
Universitätsklinikum Hamburg-EppendorfSiemens Healthcare Diagnostics IncNot yet recruitingCoronary Artery Disease | Acute Ischemic Stroke
-
University Hospital Inselspital, BerneStanley Thomas Johnson Foundation, Bern, SwitzerlandCompletedEmbolism, PulmonarySwitzerland
-
Seoul National University Bundang HospitalCompletedDiabetes Mellitus | Coronary AtherosclerosisKorea, Republic of
-
University of EdinburghNHS Lothian; NHS Greater Glasgow and Clyde; University of Glasgow; Chief Scientist...RecruitingCardiovascular Diseases | Kidney Transplant; ComplicationsUnited Kingdom
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruitingLung Cancer | Pulmonary EmbolismChina
-
Assiut UniversityRecruiting
-
National University of Ireland, Galway, IrelandGE Healthcare; HeartFlow, Inc.RecruitingMyocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive DiseasesItaly, Belgium, Germany
-
Erasmus Medical CenterRecruitingCoronary Artery DiseaseNetherlands